Old Web
English
Sign In
Acemap
>
Paper
>
Preclinical evaluation of CDK4/6 inhibitors in mesotheliomas
Preclinical evaluation of CDK4/6 inhibitors in mesotheliomas
2017
Sabine Paternot
Eric Raspé
Myriam Remmelink
Marieke Hylebos
Jan P. van Meerbeeck
Paul De Vuyst
Thierry Berghmans
Pierre P. Roger
Keywords:
Cancer research
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]